Corticosteroids and Surfactant for Prevention of Neonatal RDS
Author:
- 1 January 1993
- journal article
- research article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 25 (3) , 285-288
Abstract
Two main strategies are available for the prevention of neonatal respiratory distress syndrome (RDS) in cases of preterm delivery: antenatal administration of hormones that accelerate fetal lung maturation, and prophylactic treatment with surfactant soon after birth. The efficacy of each of these therapeutic regimens has been well documented in large randomized clinical trials, and recent data furthermore indicate that, in preterm babies with lowered risk of RDS after antenatal cortlcosteroid treatment, the odds for developing RDS are not further reduced by prophylactic treatment with surfactant. Corticosteroids and surfactant operate by clearly different mechanisms. The steroids stimulate (via the fibroblast-pneumonocyte factor) production of surfactant phospholipids by alveolar type II cells, enhance the expression of surfactant-associated proteins, reduce microvascular permeability, and accelerate overall structural maturation of the lungs. However, the increment in pool size of surfactant resulting from antenatal treatment with corticosteroids is trivial relative to the dose of exogenous surfactant required for successful prophylaxis at birth. Data from animal experiments indicate that antenatal corticosteroids and postnatal surfactant treatment have synergistic beneficial effects on neonatal lung function, and that these effects can be further potentiated by adding antenatal administration of thyrotrophin releasing hormone (TRH). Promising results have been obtained in recent clinical trials combining antenatal treatment with corticosteroids and TRH for prevention of RDS.Keywords
This publication has 29 references indexed in Scilit:
- Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoidThe Lancet, 1992
- The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trialsBJOG: An International Journal of Obstetrics & Gynaecology, 1990
- Immunochemical and Immunohistochemical Evaluation of Lung Permeability in Ventilated Newborn RabbitsExperimental Lung Research, 1990
- Regulation of messenger RNAs for the hydrophobic surfactant proteins in human lung.Journal of Clinical Investigation, 1989
- Corticosteroids and surfactant change lung function and protein leaks in the lungs of ventilated premature rabbits.Journal of Clinical Investigation, 1987
- Increases in the 35kDa surfactant‐associated protein and its mRNA following in vivo dexamethasone treatment of fetal and neonatal ratsElectrophoresis, 1987
- A Protein That Inhibits Surfactant in Respiratory Distress SyndromeNeonatology, 1986
- Leakage of protein in the immature rabbit lung; effect of surfactant replacementRespiration Physiology, 1985
- Lung Maturation in the Fetal Rat: Acceleration by Injection of Fibroblast-Pneumonocyte FactorScience, 1979
- PREMATURE DELIVERY OF FOETAL LAMBS INFUSED WITH GLUCOCORTICOIDSJournal of Endocrinology, 1969